Earnings season is in full swing, and major domestic pharmaceutical companies arrived with decidedly mixed results. Let's see how Big Pharma fared over the spring months on a company-specific basis.
Johnson & Johnson
Bristol-Myers Squibb
Eli Lilly
Merck
And then there's Pfizer
There you have it. Stay tuned for future reports on the international pharmaceutical companies as well as the more focused biotechs. In the meantime, don't forget to add all five companies I've discussed today to your Watchlist and never worry about missing out on an important development again.